Trial Profile
To identify the relationship between age related weight loss and Raloxifene treatment in osteoporotic postmenopausal women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2017
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 03 Apr 2017 New trial record